Non-Hodgkin Lymphoma Perspective

• Diagnostic Technology Is Great...Until It Isn't Cutting-edge diagnostics are miracles of modern medicine, but their help can come at a high price.
  Medscape Blogs, July 20, 2021
• EHA 2021 Read clinically focused news coverage of key developments from EHA 2021
  Medscape Oncology, June 11, 2021
• Uncommon Malignancies: Managing Rare Non-Hodgkin Lymphomas: A Lasting Response   The oncologists discuss criteria for recommending a more aggressive approach in the treatment of mantle cell lymphoma, including stem cell transplant.
  Medscape TV, May 24, 2021
• Uncommon Malignancies: Managing Rare Non-Hodgkin Lymphomas: Diverse Presentation of MCL   Oncologists discuss the symptoms of aggressive mantle cell lymphoma and the usefulness of MIPI scores to gauge risk and guide frontline treatment decisions.
  Medscape TV, April 09, 2021
• MGUS, SPEP, and the Shaka Sign   With the right threshold of suspicion, a patient's life may be saved.
  The Curbsiders, February 05, 2021
• Uncommon Malignancies: Managing Rare Non-Hodgkin Lymphomas: Indolent but Incurable   Oncologists report on when to initiate therapy in Waldenstrom macroglobulinemia and the multiple, effective chemo-immunotherapy options available.
  Medscape TV, January 21, 2021
• Highlights in Mantle Cell Lymphoma From ASH 2020   Dr Amanda Cashen from Washington University reviews key studies on mantle cell lymphoma from ASH 2020, including new data on chemotherapy-free frontline options and CAR T-cell therapy.
  Medscape, December 29, 2020
• Uncommon Malignancies: Managing Rare Non-Hodgkin Lymphomas: Working Up Waldenstrom’s   The oncologists discuss ways to distinguish WM from other low-grade lymphomas, as well as the role of observation prior to treatment.
  Medscape TV, November 12, 2020
• Uncommon Malignancies: Managing Rare Non-Hodgkin Lymphomas   Oncologists from Washington University in St. Louis discuss the diagnosis of rare B-cell non-Hodgkin lymphomas as well as current treatment strategies for both indolent and aggressive subtypes.
  Medscape TV, September 01, 2020
• IWMF 2020 Read clinically focused news coverage of key developments from IWMF 2020
  Medscape Oncology, August 28, 2020
• Preparticipation CV Screening: Who Gets the Red Card?   Which cardiac conditions are disqualifying for kids who play sports? From hypertrophic cardiomyopathy to heart transplant, Mayo Clinic's Jonathan Johnson and Bernard Gersh have answers that may surprise you.
  Mayo Clinic, August 12, 2020
• Highlights in Non-Hodgkin Lymphoma From ASCO 2020   Highlights in non-Hodgkin lymphoma from the ASCO 2020 virtual annual meeting include new data on CAR T cells in relapsed/refractory NHL, and Bcl-2 inhibition and chemoimmunotherapy in Richter syndrome.
  Medscape, June 23, 2020
• EHA 2020 Read clinically focused news coverage of key developments from EHA 2020
  Medscape Oncology, June 15, 2020
• Top News From ASH 2019: Slideshow Highlights include the exciting prospect of an off-the-shelf product to rival CAR T cells, practice-changing studies on two leukemias, plus 'Choosing Wisely' advice for children.
  Medscape News Slideshows, January 09, 2020
• Mantle Cell Lymphoma Highlights From 2019 ASH Annual Meeting   Dr Peter Martin of Weill Cornell Medicine in New York reviews key studies in front-line therapy and CAR T-cell therapy for patients with mantle cell carcinoma, presented at the 2019 ASH annual meeting.
  Medscape, January 03, 2020
• Mosunetuzumab for Aggressive Lymphoma: 'Not a Home Run'   Dr Ann LaCasce gives her take on whether the investigational agent mosunetuzumab fills an 'unmet need' for aggressive lymphoma.
  Medscape Oncology, January 02, 2020
• CAR T-Cell Highlights From the 2019 ASH Annual Meeting   Dr Michael Bishop highlights new CAR T-cell therapies presented at the 2019 ASH annual meeting that are likely to garner approvals in the near future.
  Medscape, January 02, 2020
• Healthcare Terms Are Out of Touch, Says Mom Advocate   Using terms like 'customer' and 'consumer' take the humanity out of medicine, says patient/family engagement consultant Hala Durrah in her interview with Eric Topol.
  Medscape, October 21, 2019
• Two Truths and a Lie About Pathology Poor collaboration between pathologists and clinicians means both small misunderstandings and large misconceptions.
  Medscape Oncology, October 08, 2019
• Chronic Lymphocytic Leukemia: 5 Things to Know The most common adult leukemia has seen a rush of new evidence in recent years. Here are some of the highlights.
  Medscape Oncology, September 24, 2019